LMAT (LMAT) Stock Analysis

LMAT (LMAT) is a publicly traded company in the HEALTHCARE sector. It trades at $91.62, carries a market capitalization of $2.09B, a price-to-earnings ratio of 33.61. This page summarizes the public market data, fundamentals, and frequently asked questions for LMAT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $91.62
• Market Cap: $2.09B
• P/E Ratio: 33.61
• EPS: $2.72
• 52-Week High: $117.72
• 52-Week Low: $78.29

Market Sentiment

LMAT currently has a Bullish sentiment score of 0.32.

About LMAT

LeMaitre Vascular, Inc. is a prominent player in the medical device industry, specializing in products and implants for the treatment of peripheral vascular diseases on a global scale. Based in Burlington, Massachusetts, the company is dedicated to innovation and quality, providing essential tools and devices that enhance the capabilities of vascular surgeons. With a strong focus on improving patient outcomes, LeMaitre Vascular has established itself as a reliable partner for healthcare provi...

GNG Research Analysis

GNG Research scores LMAT (LMAT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LMAT.

Frequently Asked Questions

Does LMAT pay dividends?

LMAT (LMAT) does not currently pay a regular dividend.

What is LMAT's P/E ratio?

LMAT has a price-to-earnings (P/E) ratio of 33.61.

What is LMAT's market cap?

LMAT (LMAT) has a market capitalization of $2.09B with a current stock price of $91.62.